Ipilimumab Improves Overall Survival in Previously Treated, Advanced Melanoma Patients with Good and Poor Prognostic Factors

被引：0
|
作者：
O'Day, Steven J. [1 ,2 ]
McDermott, David F. [10 ]
Urba, Walter J. [4 ]
Wolchok, Jedd D. [5 ]
Robert, Caroline [6 ]
Haanen, John B. [7 ]
Dummer, Reinhard [8 ]
Messina, Marianne [9 ]
Hoos, Axel [9 ]
Hodi, F. Stephen [3 ]
机构：
[1] Angeles Clin, Los Angeles, CA USA
[2] Res Inst, Los Angeles, CA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Earle A Chiles Res Inst, Portland, OR USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[6] Inst Gustave Roussy, Villejuif, France
[7] Netherlands Canc Inst, Amsterdam, Netherlands
[8] Univ Hosp, Zurich, Switzerland
[9] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：905 / 906
页数：2
相关论文
共 50 条
  • [41] Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma
    Motzer, RJ
    Bacik, J
    Schwartz, LH
    Reuter, V
    Russo, P
    Marion, S
    Mazumdar, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 454 - 463
  • [42] Prognostic Factors for Survival in Patients With Recurrent Cervical Cancer Previously Treated With Radiotherapy
    Mabuchi, Seiji
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Temma, Kumiko
    Takeda, Takashi
    Yamamoto, Toshiya
    Enomoto, Takayuki
    Morishige, Kenichirou
    Inoue, Takehiro
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 834 - 840
  • [43] Predictive immune markers in advanced melanoma patients treated with ipilimumab
    Umansky, Viktor
    Utikal, Jochen
    Gebhardt, Christoffer
    ONCOIMMUNOLOGY, 2016, 5 (06):
  • [44] First-line nivolumab plus ipilimumab in advanced melanoma patients previously treated with adjuvant systemic therapy
    Kozak, K.
    Teterycz, P.
    Galus, L.
    Mackiewicz, J.
    Brandys, P.
    Cybulska-Stopa, B.
    Kempa-Kaminska, N.
    Zietek, M.
    Zubrowska, J.
    Dziura, R.
    Sobczuk, P.
    Czarnecka, A. M.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S666 - S666
  • [45] Safety and efficacy of ipilimumab with or without prophylactic budesonide in treatment-naive and previously treated patients with advanced melanoma
    Weber, J. S.
    Berman, D.
    Siegel, J.
    Minor, D.
    Amin, A.
    Thompson, J. A.
    Ron, I.
    Ridolfi, R.
    Assi, H.
    Hamid, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Prognostic Factors Associated with Overall Survival in Croatian Patients with Advanced Lung Cancer
    Trivanovic, Dragan
    Kocic, Lidija
    Dembic, Marina
    Spasic, Nika
    Budisavljevic, Anuska
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S642 - S642
  • [47] Ipilimumab Exposure-Response (E-R) Analysis of Overall Survival (OS) in Patients with Advanced Melanoma
    Vezina, Heather E.
    Feng, Yan
    Roy, Amit
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S28 - S28
  • [48] Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
    Theurich, Sebastian
    Rothschild, Sacha I.
    Hoffmann, Michael
    Fabri, Mario
    Sommer, Andrea
    Garcia-Marquez, Maria
    Thelen, Martin
    Schill, Catherine
    Merki, Ramona
    Schmid, Thomas
    Koeberle, Dieter
    Zippelius, Alfred
    Baues, Christian
    Mauch, Cornelia
    Tigges, Christian
    Kreuter, Alexander
    Borggrefe, Jan
    von Bergwelt-Baildon, Michael
    Schlaak, Max
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (09) : 744 - 754
  • [49] PROJECTING LONG TERM OVERALL SURVIVAL BENEFIT IN METASTATIC MELANOMA PATIENTS TREATED WITH IPILIMUMAB USING EXTRAPOLATION METHODS
    Kim, Hansoo
    Cook, Greg
    McCloud, Philip
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 313 - 313
  • [50] Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab
    Maloney, Anna K.
    Giobbie-Hurder, Anita
    Katukota, Nikita
    Fogarasi, Miklos C.
    Ott, Patrick A.
    Hodi, F. Stephen
    Sussman, Tamara A.
    Silk, Ann W.
    Haq, Rizwan
    Liu, David
    Insco, Megan
    Buchbinder, Elizabeth, I
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (08)
12345